middl
east
respiratori
syndrom
coronaviru
merscov
recent
describ
coronaviru
high
mortal
novemb
confirm
case
death
http
mer
diseas
character
primarili
respiratori
symptom
sever
patient
also
develop
renal
failur
drosten
et
al
case
report
thu
far
immunosuppress
type
medic
disord
associ
sever
diseas
assiri
et
al
sequenc
rna
genom
merscov
similar
bat
coronavirus
howev
origin
merscov
known
recent
report
show
dromedari
camel
high
level
neutral
serum
antibodi
merscov
suggest
possibl
zoonot
sourc
reusken
et
al
addit
analysi
fecal
sampl
bat
identifi
egyptian
tomb
bat
potenti
sourc
infect
memish
et
al
work
need
identifi
anim
reservoir
merscov
limit
humantohuman
transmiss
merscov
report
consid
high
mortal
rais
concern
viru
potenti
becom
threat
public
health
assiri
et
al
gueri
et
al
similar
sever
acut
respiratori
syndrom
coronaviru
sarscov
sarscov
pandem
control
public
health
measur
identif
isol
infect
symptomat
individu
contact
broke
chain
humantohuman
transmiss
sarscovlik
viru
endem
chines
horsesho
bat
chang
sequenc
spike
glycoprotein
requir
viru
effici
infect
human
lau
et
al
rockx
et
al
merscov
unclear
viru
jump
directli
bat
human
mutat
viral
genom
facilit
infect
diseas
human
symptomat
asymptomat
case
would
make
potenti
epidem
difficult
control
public
health
measur
alon
goal
appli
knowledg
gain
studi
sarscov
identifi
character
merscov
papainlik
proteas
domain
innat
immun
antagonist
potenti
target
therapeut
merscov
similar
coronavirus
positivestrand
rna
viru
upon
entri
cell
translat
produc
viral
replicas
polyprotein
replicas
polyprotein
process
viral
proteas
gener
membraneassoci
viral
replic
complex
snijder
et
al
perlman
netland
sequenc
analysi
merscov
indic
canon
papainlik
proteas
plpro
proteinas
like
respons
process
polyprotein
gener
nonstructur
protein
assembl
form
replic
complex
major
coronaviru
papainlik
proteas
plp
includ
sarscov
plpro
shown
thu
far
act
deubiquitinas
interferon
antagonist
clementz
et
al
frieman
et
al
ratia
et
al
zheng
et
al
xing
et
al
barretto
et
al
sulea
et
al
chen
et
al
ubiquitin
pathway
import
regul
number
innat
immun
pathway
abil
viral
protein
cleav
ubiquitin
host
cell
protein
contribut
viru
pathogenesi
addit
ubiquitin
modif
cellular
protein
interferonstimul
gene
known
broadspectrum
antivir
activ
ubiquitinlik
protein
conjug
cellular
target
via
mechan
call
isgyl
regul
innat
immun
respons
coronaviru
plp
known
abil
remov
conjug
cellular
substrat
clementz
et
al
lindner
et
al
lindner
et
al
studi
demonstr
deisgyl
deubiquitin
dub
activ
papainlik
proteas
merscov
provid
new
inform
potenti
role
coronaviru
proteasedub
inhibit
innat
immun
respons
merscov
plpro
encod
within
nonstructur
protein
replicas
polyprotein
fig
gain
insight
potenti
merscov
plpro
recogn
cleav
ubiquitin
protein
use
highresolut
xray
structur
sarscov
plpro
apoenzym
form
chain
c
gener
homolog
model
merscov
plpro
thread
merscov
primari
amino
acid
sequenc
sarscov
structur
energi
minim
structur
homolog
model
display
sever
conserv
structur
featur
merscov
sarscov
plpro
includ
ubiquitinlik
domain
ubl
catalyt
triad
consist
ubiquitinbind
domain
zinc
finger
model
ubiquitin
ub
zinc
finger
palm
domain
merscov
plpro
use
xray
structur
associ
electron
densiti
sarscov
plpro
complex
ub
aldehyd
ubal
refin
energi
minim
model
complex
ub
result
merscovub
model
display
nearli
ideal
fit
ub
moieti
within
palm
zinc
finger
region
enzym
ctermin
extens
ubiquitin
orient
properli
toward
merscov
substrat
subsit
catalyt
triad
fig
model
hypothes
plpro
domain
merscov
like
sarscov
multifunct
enzym
proteas
deubiquitin
like
deisgyl
activ
recent
describ
express
proteas
activ
merscov
plpro
cell
cultur
kilianski
et
al
determin
deisgyl
activ
merscov
plpro
transfect
cell
plasmid
conjug
machineri
increas
amount
plasmid
express
merscov
plpro
wildtyp
catalyt
mutant
plproca
cystein
predict
activ
site
cystein
nucleophil
attack
substrat
peptid
bond
mutat
alanin
significantli
reduc
abolish
enzymat
activ
fig
addit
transfect
cell
plasmid
express
sarscov
plpro
wildtyp
catalyt
mutant
harvest
cell
lysat
h
posttransfect
evalu
presenc
isgyl
protein
found
merscov
sarscov
plpro
deconjug
multipl
cellular
substrat
dosedepend
manner
contrast
plpro
catalyt
mutant
deconjug
indic
catalyt
activ
plpro
requir
deisgyl
activ
fig
thu
merscov
plpro
like
sarscov
plpro
lindner
et
al
deisgyl
activ
assess
dub
activ
merscov
plpro
transfect
cell
plasmid
express
flagub
increas
amount
wildtyp
plpro
plproca
determin
plpro
deubiquitin
multipl
cellular
substrat
plpro
catalyt
activ
requir
dub
activ
fig
dub
activ
also
observ
express
sarscov
plpro
consist
previou
report
frieman
et
al
ratia
et
al
barretto
et
al
lindner
et
al
lindner
et
al
experi
notic
differ
express
level
sarscov
merscov
plpro
transfect
cell
may
due
differ
codon
optim
merscov
plpro
construct
vitro
studi
use
purifi
enzym
need
determin
rel
kinet
sarscov
merscov
plpro
dub
deisgyl
activ
taken
togeth
data
indic
merscov
plpro
potent
deisgyl
enzym
also
exhibit
dub
activ
activ
requir
cystein
catalysi
like
context
predict
catalyt
triad
fig
coronaviru
plp
shown
block
interferon
induct
transfect
cell
clementz
et
al
frieman
et
al
devaraj
et
al
addit
deubiquitinas
function
arteriviru
papainlik
proteas
shown
role
interferon
antagon
viru
infect
van
kasteren
et
al
therefor
assess
abil
merscov
plpro
antagon
interferon
product
first
address
merscov
plpro
inhibit
induc
report
sinc
implic
recognit
coronavirus
viru
infect
zust
et
al
transfect
cell
plasmid
express
renilla
luciferas
rothenfuss
et
al
increas
amount
wildtyp
plpro
plproca
h
posttransfect
assess
luciferas
report
activ
determin
merscov
plpro
potent
inhibit
mediat
induct
dosedepend
manner
catalyt
activ
merscov
plpro
requir
antagon
fig
use
overexpress
activ
form
rigi
determin
merscov
plpro
also
inhibit
nrigi
induc
report
similarli
experi
stimul
catalyt
activ
merscov
plpro
necessari
antagon
upon
nrigi
stimul
fig
upon
recognit
viral
rna
pattern
recognit
receptor
prr
rigi
signal
transmit
downstream
via
mitochondri
antivir
signal
protein
mav
thu
test
plpro
abl
inhibit
mav
induc
report
stimul
report
overexpress
pefbosmav
rothenfuss
et
al
cell
coexpress
report
either
wildtyp
plpro
plproca
found
plpro
plproca
inhibit
mav
induc
report
fig
final
test
abil
merscov
plpro
inhibit
report
activ
observ
sarscov
plpro
transfect
cell
plasmid
express
luciferas
renilla
luciferas
merscov
wildtyp
plpro
plproca
treat
cell
activ
pathway
harvest
cell
lysat
h
posttreat
assess
luciferas
activ
determin
wildtyp
plpro
reduc
induct
report
dosedepend
manner
catalyt
cystein
residu
requir
activ
fig
taken
togeth
result
indic
merscov
plpro
interferon
antagonist
catalyt
activ
requir
antagon
addit
plpro
reduc
induct
report
activ
catalyt
activ
also
requir
investig
role
coronaviru
plpro
inhibit
innat
immun
respons
test
effect
merscov
plpro
express
endogen
cytokin
first
use
human
innat
adapt
immun
respons
pcr
array
sabiosci
determin
cell
rant
mrna
level
upregul
upon
stimul
data
shown
therefor
select
gene
analysi
determin
effect
merscov
plpro
sarscov
plpro
cytokin
express
perform
qrtpcr
measur
mrna
encod
level
presenc
cov
plpro
cell
transfect
wildtyp
catalyt
mutant
merscov
sarscov
plpro
h
posttransfect
total
rna
extract
qrtpcr
perform
found
merscov
sarscov
plpro
potent
inhibit
reduct
express
upon
stimul
catalyt
activ
requir
inhibit
fig
agreement
result
luciferas
report
assay
observ
express
stimul
cell
inhibit
presenc
wildtyp
merscov
plpro
sarscov
plpro
fig
mrna
level
also
significantli
reduc
wildtyp
catalyt
mutant
version
merscov
plpro
sarscov
plpro
express
fig
knowledg
first
report
show
merscov
plpro
sarscov
plpro
reduc
induct
endogen
proinflammatori
cytokin
cell
mechan
requir
catalyt
activ
virus
must
less
compact
natur
genom
one
exampl
multifunct
plp
domain
encod
member
order
nidoviral
nidovirus
includ
coronaviru
arteriviru
famili
encod
one
plp
domain
plp
critic
proteolyt
process
viral
replicas
polyprotein
addit
proteas
activ
mani
plp
also
shown
act
viral
deubiquitin
enzym
dub
abl
deconjug
ubiquitin
cellular
substrat
coronaviru
dub
activ
first
propos
molecular
model
sarscov
plpro
domain
predict
proteas
may
multifunct
inde
analysi
dub
activ
purifi
cov
plp
xray
crystal
structur
sarscov
plpro
fulli
support
initi
predict
viral
dub
activ
ratia
et
al
barretto
et
al
lindner
et
al
ratia
et
al
analysi
plp
coronavirus
arterivirus
reveal
conserv
dub
activ
although
enzym
coronaviru
famili
fall
ubiquitin
specif
proteas
usp
famili
wherea
arteriviru
plp
ovarian
tumor
otu
domain
famili
enzym
identif
newli
emerg
coronaviru
merscov
provid
opportun
evalu
plpro
enzymat
activ
develop
new
hypothes
proteasedub
may
contribut
viral
pathogenesi
model
merscov
plpro
domain
onto
structur
sarscov
led
predict
viral
dubdeisgyl
activ
although
enzym
ident
sarscov
plpro
amino
acid
level
show
deisgyl
dub
interferon
antagon
activ
conserv
importantli
show
coronaviru
plpro
activ
modul
innat
immun
respons
coronavirus
shown
modul
immun
respons
upon
infect
howev
mechan
involv
regul
yet
clear
totura
baric
cytokin
chemokin
respons
sarscov
nonlymphat
cell
infect
patient
result
low
level
sever
cytokin
includ
wong
et
al
spiegel
weber
addit
among
other
induc
clone
bronchial
epitheli
cell
line
human
alveolar
type
ii
cell
infect
sarscov
earli
post
infect
yoshikawa
et
al
qian
et
al
innat
immun
respons
merscov
also
intrigu
microarray
analysi
merscov
infect
cell
result
distinct
immun
respons
compar
sarscov
infect
express
multipl
gene
involv
activ
adapt
immun
respons
mhc
class
ii
downregul
merscov
infect
cell
josset
et
al
abil
sarscov
merscov
modul
earli
immun
respons
like
due
multipl
protein
encod
within
viru
genom
may
act
interferon
antagonist
previou
report
show
sever
coronaviru
protein
block
activ
innat
immun
respons
particularli
product
induct
respons
review
totura
baric
structur
protein
sarscov
nucleocapsid
n
membran
protein
addit
critic
element
viral
particl
shown
block
ifn
respons
sever
accessori
protein
sarscov
mous
hepat
viru
known
act
antagonist
innat
immun
kopeckybromberg
et
al
zhao
et
al
inde
merscov
accessori
protein
report
block
induct
ifn
niemey
et
al
addit
nonstructur
protein
includ
implic
ifn
antagonist
frieman
et
al
kamitani
et
al
importantli
plp
encod
within
shown
block
induct
sarscov
plpro
interferon
antagonist
catalyt
activ
import
plpro
antagon
clementz
et
al
frieman
et
al
devaraj
et
al
sarscov
plpro
plp
sarscov
genom
deisgyl
deubiquitin
enzym
ratia
et
al
lindner
et
al
lindner
et
al
hand
encod
two
papainlik
proteas
genom
homolog
sarscov
plpro
ifn
antagonist
deisgyl
dub
activ
clementz
et
al
devoid
activ
addit
mous
hepat
viru
porcin
epidem
diarrhea
viru
plp
dub
activ
act
ifn
antagonist
zheng
et
al
xing
et
al
plp
arterivirus
also
known
block
ifn
respons
n
termin
region
encod
papainlik
proteas
porcin
reproduct
respiratori
syndrom
viru
prrsv
plp
character
otu
deubiquitin
deisgyl
abil
friasstah
et
al
addit
sun
et
al
show
prrsv
plp
domain
block
sendai
viru
induc
also
inhibit
prevent
degrad
deubiquitin
recent
report
show
prrsv
plp
also
deisgyl
activ
suggest
multipl
role
prrsv
papainlik
proteas
antagon
innat
immun
sun
et
al
anoth
member
arterivirida
equin
arter
viru
eav
deubiquitin
deisgyl
activ
well
friasstah
et
al
deubiquitin
abil
eav
plp
block
rigi
induc
ifn
inhibit
ubiquitin
rigi
requir
activ
cocryst
structur
eav
plp
ubiquitin
revel
potenti
interact
site
molecul
mutagenesi
studi
show
plp
dub
activ
requir
inhibit
innat
immun
infect
cell
van
kasteren
et
al
specif
deubiquitin
deisgyl
activ
shown
crimeancongo
hemorrhag
fever
viru
cchfv
highli
pathogen
negativestrand
rna
viru
belong
famili
bunyavirida
l
proteas
cchfv
contain
otu
domain
abil
cleav
modif
l
proteas
remov
immun
protect
type
ifn
receptor
knockout
mice
make
highli
suscept
sindbi
viru
infect
friasstah
et
al
overal
result
multipl
laboratori
studi
varieti
coronaviru
arteriviru
bunyaviru
proteas
indic
deubiquitin
deisgyl
activ
viral
proteas
import
role
inhibit
innat
immun
respons
possibl
viru
pathogenesi
character
papainlik
proteas
merscov
reveal
deisgyl
deubiquitin
activ
act
interferon
antagonist
show
first
time
sarscov
plpro
merscov
plpro
block
induct
sever
endogen
proinflammatori
cytokin
data
suggest
antagon
innat
immun
respons
mediat
merscov
sarscov
plpro
limit
may
affect
express
mani
cellular
cytokin
result
suggest
plpro
might
contribut
modul
innat
immun
respons
upon
sarscov
merscov
infect
howev
exact
mechan
role
coronaviru
plp
associ
dub
deisgyl
activ
process
remain
determin
crystal
structur
sarscov
plpro
use
templat
structur
gener
homolog
model
merscov
plpro
use
autom
webbas
homolog
model
server
bimolecular
model
laboratori
cancer
research
uk
england
program
suit
coot
version
use
final
refin
energi
minim
model
ub
zinc
finger
palm
region
merscov
plpro
use
electron
densiti
sarscov
plpro
complex
ubiquitinaldehyd
cell
cultur
dulbecco
modifi
eagl
medium
dmem
fetal
calf
serum
fc
glutamin
transfect
perform
confluent
cell
cell
bind
plate
corn
use
reagent
miru
accord
manufactur
protocol
merscov
plpro
pcdnamersplpro
express
plasmid
gener
catalyt
mutant
describ
previous
kilianski
et
al
pcdnasarsplpro
wildtyp
catalyt
mutant
express
plasmid
describ
elsewher
barretto
et
al
luciferas
assay
experi
use
deisgyl
activ
assay
cell
plate
transfect
ng
pcdnamersplpro
wildtyp
catalyt
mutant
ng
ng
ng
ng
h
posttransfect
cell
lyse
lysi
buffer
mm
tri
ph
mm
nacl
mm
egta
mm
edta
triton
mm
na
pyrophosph
mm
betaglycerophosph
mm
na
orthovanad
mgml
leupeptin
protein
separ
sdspage
transfer
pvdf
membran
use
semidri
transfer
apparatu
biorad
follow
transfer
membran
block
use
dri
skim
milk
tbst
buffer
nacl
mm
trishcl
ph
tween
overnight
membran
incub
mous
antimyc
antibodi
mbl
dilut
membran
wash
time
min
tbst
buffer
follow
membran
incub
secondari
goatantimousehrp
antibodi
dilut
amersham
membran
wash
time
min
tbst
buffer
detect
perform
use
western
light
chemiluminesc
reagent
plu
perkinelm
visual
use
fluorochem
imag
protein
simpl
verifi
express
plpro
membran
probe
mous
antibodi
invitrogen
dilut
mous
anticalnexin
antibodi
cell
signal
dilut
use
determin
load
standard
assess
dub
activ
cell
plate
transfect
ng
mg
pcdnamersplpro
wildtyp
catalyt
mutant
h
posttransfect
cell
lyse
ml
lysi
buffer
protein
separ
sdspage
transfer
pvdf
membran
describ
membran
probe
perform
use
mous
antiflag
antibodi
sigma
dilut
cell
plate
transfect
ng
renillaluciferas
ng
ng
pcdnamersplpro
wildtyp
catalyt
mutant
express
plasmid
stimul
ng
pefbo
ng
pefbo
mav
ng
nrigi
per
well
transfect
empti
vector
plasmid
use
standard
total
amount
dna
use
transfect
h
posttransfect
cell
lyse
use
passiv
lysi
buffer
promega
altern
cell
transfect
ng
hyrgo
ng
wildtyp
catalyt
mutant
h
treat
ngml
roch
h
lyse
experi
firefli
renilla
luciferas
measur
use
dual
luciferas
report
assay
system
promega
luminomet
verita
result
normal
renilla
luciferas
express
control
experi
perform
triplic
remain
lysat
incub
lysi
buffer
nacl
mm
trishcl
ph
analyz
sdspage
describ
cell
plate
transfect
ng
pefbo
ng
pcdnamersplpro
wildtyp
catalyt
mutant
express
plasmid
ng
pcdnasarsplpro
wildtyp
catalyt
mutant
express
plasmid
empti
vector
plasmid
vector
use
standard
total
amount
dna
sampl
cell
lyse
h
posttransfect
buffer
rlt
qiagen
rna
extract
use
rneasi
mini
qiagen
revers
transcript
perform
use
mg
total
rna
rt
first
strand
kit
qiagen
accord
manufactur
protocol
ml
cdna
use
set
qrtpcr
reaction
accord
manufactur
protocol
use
singl
primer
assay
sabiosci
c
valu
normal
housekeep
gene
